The startup focuses on identifying and analyzing specific cell types that contribute to the persistence of incurable diseases. By utilizing advanced cellular profiling techniques, the company aims to provide insights that can lead to targeted therapies and improved treatment outcomes.
Funding
$5.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Many incurable diseases persist due to the activity of specific cell types that are difficult to identify and target with conventional therapies. A lack of precise tools for cellular profiling hinders the development of effective treatments.
Solution
This startup focuses on identifying and analyzing specific cell types that contribute to the persistence of incurable diseases. By employing advanced cellular profiling techniques, the company aims to provide insights that can lead to the development of targeted therapies and improved treatment outcomes. Their approach involves isolating and characterizing these disease-driving cells to understand their unique properties and vulnerabilities. This knowledge is then leveraged to design novel therapeutic strategies that selectively eliminate or modulate these cells, ultimately disrupting the disease process and promoting remission. The company's platform offers a comprehensive solution for researchers and drug developers seeking to tackle challenging diseases at the cellular level.
Target Audience
The primary target audience includes pharmaceutical companies, biotechnology firms, and academic research institutions involved in drug discovery and development for incurable diseases.
Features
- Proprietary cell isolation methods for obtaining pure populations of disease-relevant cell types
- Multi-omic profiling technologies, including single-cell RNA sequencing and proteomics, to characterize cellular phenotypes
- Advanced bioinformatics pipelines for identifying key molecular drivers of disease persistence
- Target discovery platform for identifying novel therapeutic targets specific to disease-driving cells